Careers: Overview

FIND YOUR FUTURE

Searching for a career opportunity at AVITA Medical? Explore our open positions, or submit your resume.

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration. AVITA Medical is advancing the standard of care for burn patients with its novel technology platform, the RECELL® System.

AVITA Medical company photo
AVITA Medical company hike photo

Our proprietary technology provides innovative treatment solutions derived from the skin’s own regenerative properties. The medical device works by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural, healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.

AVITA Medical introduced the RECELL® System to the U.S. in September 2018. As the first new PMA-approved treatment for burn care in more than 20 years, the RECELL® System represents a major advancement over the current standard of care for burn patients, offering benefits in both clinical outcomes and cost savings.

Working at AVITA Medical

Every day AVITA Medical’s RECELL® system changes lives. Every day you are part of that experience with a people that are committed to this mission. Located in Valencia, California, immediately across the freeway from Magic Mountain you become part of a family that looks to improve lives every day. Everyone has a stake in the outcomes of our patients and the company. The energy that is brought to all of our locations truly is inspiring and motivating.

Become part of the story that is AVITA Medical and help us continue to bring patient care to new heights!

Benefits available to AVITA Medical employees include:

  • Stock Options
  • 401k with a Generous Match
  • Multiple Health Care Plans
  • Dental/Vision
  • Company-sponsored Short-Term Disability, Long-Term Disability and Life Insurance

The teams that work at AVITA Medical make all the difference  — Join us!

Avita Medical Careers 3
Avita Medical Careers
Avita Medical Careers 5
AVITA Medical Careers 3

SUBMIT YOUR RESUME

IMPORTANT SAFETY INFORMATION (United States)

INDICATIONS FOR USE: The RECELL® Autologous Cell Harvesting Device is indicated for the treatment of acute thermal burn wounds. The RECELL® device is used by an appropriately-licensed healthcare professional at the patient’s point of care to prepare autologous RES® Regenerative Epidermal Suspension for direct application to acute partial-thickness thermal burn wounds in patients 18 years of age and older or application in combination with meshed autografting for acute full-thickness thermal burn wounds in pediatric and adult patients.

CONTRAINDICATIONS: RECELL® is contraindicated for: the treatment of wounds clinically diagnosed as infected or with necrotic tissue, the treatment of patients with a known hypersensitivity to trypsin or compound sodium lactate (Hartmann’s) solution, patients having a known hypersensitivity to anesthetics, adrenaline/epinephrine, povidone-iodine, or chlorhexidine solutions.

WARNINGS AND PRECAUTIONS: Autologous use only. Wound beds treated with a cytotoxic agent (e.g., silver sulfadiazine) should be rinsed prior to application of the cell suspension. RECELL® is provided sterile and is intended for single-use. Do not use if packaging is damaged or expired. Choose a donor site with no evidence of cellulitis or infection and process skin immediately. A skin sample should require between 15 and 30 minutes contact with Enzyme. Contact in excess of 60 minutes is not recommended. RECELL® Enzyme is animal derived and freedom from infectious agents cannot be guaranteed.

PRECAUTIONS: RECELL® is not intended for use without meshed autograft for treatment of full-thickness burn wounds. The safety and effectiveness of RECELL® without meshed autograft have not been established for treatment of partial-thickness burn wounds: on the hands and articulating joints, >320 cm2, in patients with wounds totaling >20% total body surface area (TBSA). The safety and effectiveness of RECELL with autografting have not been established for treatment of full-thickness burn wounds: on the hands and articulated joints, and in patients younger than 28 days of age (neonates).

SPECIAL PATIENT POPULATIONS: The safety and effectiveness of RECELL® have not been established for treatment of acute thermal partial-thickness burn wounds in pediatric patients younger than 18 years of age.

For complete Important Safety Information, refer to Instructions For Use. Please be aware that any indication for RECELL® outside of the United States may differ from the US indication. Please see the Instructions for Use for each country for the specific indication of RECELL®.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.
©Copyright 2022 AVITA Medical. All Rights Reserved.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.
©Copyright 2022 AVITA Medical. All Rights Reserved.